Magenta Therapeutics, Inc.MGTANASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+46.0%
5Y CAGR+19.7%
Year-over-Year Change
Research and development spending
3Y CAGR
+46.0%/yr
vs +13.8%/yr prior
5Y CAGR
+19.7%/yr
Recent acceleration
Acceleration
+32.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.5x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $145.64M | +75.2% |
| 2024 | $83.11M | +50.7% |
| 2022 | $55.14M | +17.9% |
| 2021 | $46.77M | -7.6% |
| 2020 | $50.62M | -14.5% |
| 2019 | $59.21M | +43.2% |
| 2018 | $41.34M | +48.2% |
| 2017 | $27.90M | +382.5% |
| 2016 | $5.78M | - |